Kidney Disease Clinical Trials in San Antonio

Showing 161-180 of 340 trials

A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients

NCT05035641

This is a pilot phase II study to evaluate the safety and efficacy of AND017 in NDD-CKD patients

Kind Pharmaceuticals LLC113 participantsStarted Oct 2021

Northridge, California, United States • Winter Park, Florida, United States • Shreveport, Louisiana, United States +5 more locations

COMPLETEDNA< 1 mile

Study to Compare Safety and Tolerability of AKST1210 Column at 2 Blood Flow Rates in Subjects With ESRD on Hemodialysis

NCT04985383

This study is to evaluate the safety and tolerability of the AKST1210 column at blood-flow rates greater than 250 mL/min in subjects with end-stage renal disease (ESRD) undergoing hemodialysis (HD). The study will assess the safety, tolerability, and impact on HD parameters when the AKST1210 column is used at a blood-flow of up to 450 mL/min.

End-Stage Renal Disease

Alkahest, Inc.10 participantsStarted Mar 2021

Granada Hills, California, United States • Northridge, California, United States • Gallup, New Mexico, United States +1 more locations

A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients

Study to Compare Safety and Tolerability of AKST1210 Column at 2 Blood Flow Rates in Subjects With ESRD on Hemodialysis

Kidney Disease Trials in Other Cities

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency

A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma

A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Look AHEAD: Action for Health in Diabetes

A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease

A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease

A Study of Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment

Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis

A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy

Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and Hemodialysis

Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis

Other Conditions in San Antonio